RecruitingNCT06287177
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy - CHOLINET (CHOLesterol Italian Inclisiran NETwork)
Sponsor
Federico II University
Enrollment
3,000 participants
Start Date
Nov 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Evaluation of adherence, persistence and efficacy of treatment with Inclisiran in a real-life Italian population
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patients under Inclisiran treatment
Exclusion Criteria2
- Age < 18 years o > 80 years
- Patients who refuse to participate and to sign informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGInclisiran
Injection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06287177
Related Trials
Causes and Natural History of Dyslipidemias
NCT003537821 location
Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
NCT064881051 location
WB-EMS Effects on Cardiometabolic Risk Factors
NCT074061912 locations
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in Italy
NCT073748611 location
Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy
NCT0543082827 locations